Immune-Mediated Mechanisms Potentially Regulate the Disease Time-Course of Duchenne Muscular Dystrophy and Provide Targets for Therapeutic Intervention
To access this article, please choose from the options below
This CME activity is designated for 1.0 AMA PRA Category 1 Credit™ and can be completed online at me.aapmr.org. Log on to www.me.aapmr.org, go to Lifelong Learning (CME) and select Journal-based CME from the drop down menu. At $10 per activity for AAPM&R members, journal CME is a cost-effective option for obtaining Category 1 CME credit!
Disclosure Key can be found on the Table of Contents and at www.pmrjournal.org
This work was supported by the National Institutes of Health NIH Grant RO1AR049881 (RWG).
PII: S1934-1482(09)00440-7
doi:10.1016/j.pmrj.2009.04.010
© 2009 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.
